Clinical Trial

EMA-Guided Maintenance TMS for Depression

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2024 (before its estimated September 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to evaluate the use of ecological-momentary-assessment (EMA) as a method for scheduling maintenance treatments for patients with Major Depressive Disorder (MDD) who responded to an initial acute course of Transcranial Magnetic Stimulation (TMS). To assess symptom re-emergence and severity over time, the Patient Health Questionnaire-9 item (PHQ-9) will be administered weekly via a prompt with a link send to a participants' smart phones. Adaptive algorithm software will monitor each participant's PHQ-9 scores over time and determine when a threshold increase in symptoms has occured and maintenance TMS sessions should be offered. Participants in this study will be randomized to either receive weekly EMA (monitoring only) or weekly EMA with maintenance TMS sessions (scheduled as indicated by the EMA algorithm). Participation for each subject will last for one year, with maintenance TMS offered as an adjunct to ongoing treatment as usual (TAU) for depression, i.e., ongoing pharmacotherapy, psychotherapy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-17; most recent amendment 2024-12-02.
Status change: Recruiting → Active, Not Recruiting 2024-12-02
Trial Details
NCT Number NCT06145594
Lead Sponsor Butler Hospital
Conditions Major Depressive Disorder
Enrollment 30 participants
Start Date 2023-09-25
Primary Completion 2025-09-25 (estimated)
Study Completion 2026-09-25 (estimated)
Updated on ClinicalTrials.gov 2024-12-04